Surgeons in China have successfully transplanted a genetically modified pig lung into a brain dead human recipient, marking the first attempt of its kind. The lung, taken from a donor pig with six genetic modifications, functioned for nine days without triggering immediate rejection or infection, according to findings published in Nature Medicine. The experiment represents another step in xenotransplantation, a field aiming to address the global shortage of transplant organs, with only about 10% of demand currently being met.
Challenges and Future Prospects
While encouraging, experts caution that pig lungs are uniquely difficult to transplant due to their constant exposure to the external environment, making them highly vulnerable to immune reactions, pollution, and infection. Although the lung avoided hyperacute rejection, it eventually suffered antibody attacks and fluid damage despite strong immunosuppression. Researchers emphasize the need for improved genetic modifications, optimized drug regimens, and long-term studies.
Specialists note that this work is an incremental step rather than a breakthrough, as lung xenotransplantation faces greater hurdles compared to pig kidneys or hearts, which have already shown months of function in some patients. Alongside xenotransplantation, scientists are exploring alternatives such as stem-cell–based organ regeneration, humanized organs grown in animals, and reconditioning donor lungs that would otherwise be deemed unsuitable. These parallel efforts could accelerate progress toward easing the organ shortage crisis.
